The responses to Items 5-11 of the cover pages of this Schedule 13G are incorporated herein by reference.
As of October 8, 2021, Reporting Persons may be deemed to beneficially own an aggregate of 925,000 shares of Common Stock as follows: CPREF A directly held 459,311 shares of Common Stock, CPREF B directly held 459,311 shares of Common Stock and SBS II directly held 6,378 shares of Common Stock (CPREF A, CPREF B and SBS II, together the “Centerbridge Funds”), representing approximately 9.4% of the Common Stock outstanding based upon 9,880,723 shares of Common Stock outstanding upon completion of the offering described in the Issuer’s Prospectus Supplement on Form 424(b)(5), filed with the Securities Exchange Commission on October 7, 2021.
As of December 31, 2021, Reporting Persons may be deemed to beneficially own an aggregate of 978,706 shares of Common Stock as follows: CPREF A directly held 485,981 shares of Common Stock, CPREF B directly held 485,978 shares of Common Stock and SBS II directly held 6,747 shares of Common Stock, representing approximately 9.6% of the Common Stock, based upon 10,173,951 shares of Common Stock outstanding as of November 2, 2021 as reported in the quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.
As of January 14, 2022, Reporting Persons may be deemed to beneficially own an aggregate of 1,030,854 shares of Common Stock as follows: CPREF A directly held 511,874 shares of Common Stock, CPREF B directly held 511,874 shares of Common Stock and SBS II directly held 7,106 shares of Common Stock, representing approximately 10.1% of the Common Stock, based upon 10,173,951 shares of Common Stock outstanding as of November 2, 2021 as reported in the quarterly report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021.
Centerbridge GP is the general partner of each of CPREF A and CPREF B, and, as such, may be deemed to beneficially own the securities held by CPREF A and CPREF B. Cayman GP is the general partner of Centerbridge GP, and, as such, it may be deemed to beneficially own the securities held by each of CPREF II A and CPREF II B. CCP GP is the general partner of SBS II, and, as such, may be deemed to beneficially own the securities held by SBS II. Mr. Aronson, indirectly, through various intermediate entities controls each of the Centerbridge Funds, and, as such, Mr. Aronson may be deemed to beneficially own the securities held by the Centerbridge Funds.
However, none of the foregoing should be construed in and of itself as an admission by Mr. Aronson or by any Reporting Person as to beneficial ownership of securities owned by another Reporting Person. In addition, Mr. Aronson expressly disclaims beneficial ownership of the shares of Common Stock held by the Centerbridge Funds, except to the extent of any proportionate pecuniary interest therein.
ITEM 5. | Ownership of Five Percent or Less of a Class. |
Not applicable.
ITEM 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
ITEM 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. |
Not applicable.
ITEM 8. | Identification and Classification of Members of the Group. |
Not applicable.